Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Demand by Type & Route of Administration The global anesthesia drugs market will witness a robust CAGR of 3.47%, valued at $7.03 billion in 2021, expected to appreciate and reach $9.56 billion by 2030, confirms Strategic Market Research. Anesthesia can be described as a state of temporary unconsciousness, loss of pain perception, memory loss, and muscle relaxation. Most people associate the word Anesthesia with medically induced unconsciousness before surgery. Apart from the fact that Anesthesia may be a relief for those who want to avoid surgical pain, its risks can also be a concern for those who fear medically induced unconsciousness. According to statistics from 2014, the death rate due to Anesthesia (although performed by Anaesthesiologists) during surgical procedures stayed steady at three per 10,000. Between the years 2010 and 2013, the rate of complications decreased to 4.65% from 11.84%. Nausea and vomiting were the most common minor side effects of Anesthesia. In 3.2 million cases of Anesthesia administered during this period, this issue was reported in 36% of the cases. Nearly 12% of cases reported medication errors (Anesthesia Overdose/Underdose) as the most common major complication. The following conditions increase the risk of Anesthesia complications: smoking, obstructive sleep apnea, high blood pressure, obesity, diabetes, heart or lung ailments, alcoholism or Drug allergies, or any history of Anesthesia complications. There will be a greater need for Anesthesia Drugs over the next decade as the elderly population is growing at a rapid pace hence more people will require medical care. Subsequently, it will give a boost to Anesthesia Drug’s market share. Significance of Anaesthetic Drugs in the Pharmaceutical Market: - Anesthesia is a medication that prevents you from feeling pain during surgical procedures. Anaesthetics are medications that vandalize pain and help patients to relax during surgical procedures. Anesthesia has various varieties and forms like General Anesthesia Drugs, regional Anesthesia, Epidural, Spinal Anesthesia, and Nerve Block Anesthesia Drugs, Combined General and Epidural Anesthesia. Each type of Anesthesia prevents different pain sensations. Some anaesthetics can numb certain parts of the body, while other medicines can numb the brain, thereby causing sleep during more invasive surgeries, such as those that take place in the abdomen, head, or chest. Impact of Covid 19 on the Global Anesthesia Drugs Market: - A slight decline in the demand for Anesthesia Drugs was observed in 2020 as a result of the pandemic, causing delays or cancellations of surgeries. According to a study published in the British Journal of Surgery, approximately 28.4 million elective surgeries were cancelled or postponed globally in May 2020 due to the disruption of hospital services caused by COVID-19. Nevertheless, as social activities are resuming, all elective surgeries that were delayed, are being performed now, which means that Anesthesia Drugs are being consumed in greater quantities resulting in the Anesthesia Drugs market gradually picking up market growth. Market Dynamics: Driver, Restraints, Opportunity and Challenges Market Drivers and Opportunities: Increasing number of surgeries, a growing elderly population and advances in technology poised to boost the growth of the market One of the major factors driving the anaesthetics market is the increase in the number of surgeries performed, that use anaesthetics during the surgical procedure. An increase in surgeries is primarily due to the increasing incidents of traumatic injuries and accidents requiring surgical procedures. World Health Organization's Global status report on road safety 2018 shows that there are 1.35 million road accidents every year, with 64 deaths per 100,000 vehicles. Additionally, advances in technology in the delivery of Drugs, the development of specifically targeted medicines, the development of devices to monitor patients' physiological parameters during and after Anesthesia, and reduced side effects of anaesthetics are the driving factors that will boost the market growth. By 2050, one out of four people living in Europe and Northern America could be 65 years or older, according to the Department of Economic and Social Affairs of the United Nations. With an increase in the elderly population, chronic diseases such as cardiovascular and neurological are on the rise in older populations, further increasing the need for anesthesia drugs. As of June 15, 2019, Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, which is used to sedate non-intubated patients before and/or during surgery, is available from Fresenius Kabi. Due to this, the market for Global Anesthesia Drugs is expected to grow. Market Restraint: Lack of Infrastructure, Lack of Awareness and High cost of Drugs and procedures restraining the growth of the market An expected restraint in the growth of the Anesthesia Drugs market is due to the lack of healthcare facilities in underdeveloped countries and remote areas, as well as the lack of Anesthesia doctors and certified Anesthesia nurses per capita. Additionally, during the forecast period, high prices of procedures and branded Drugs will hinder the growth of this market. Lack of Anesthesia awareness among the common masses is also a condition that negatively affects the Anesthesia Drugs market. Market Challenges: Unintentional intraoperative awareness is one of the major challenges to the Anesthesia market Moreover, during the surgical process when general Anesthesia is given, approximately one or two people out of every 1000 may be unaware that they are partially awake. There is very little chance of experiencing pain, but this can also occur. Since people are being given relaxation Drugs before surgeries, they cannot move or communicate their pain or awareness to the doctors. There is the possibility that this will cause patients long-term psychological problems, similar to post-traumatic stress disorder. This is called unintentional intraoperative awareness and it is one of the major challenges to the Anesthesia market. Market Analysis Of Different Segments Covered in the Report We have segmented the Global Anesthesia Drugs Market into: Type Application Route Of Administration Regional By Type, the Global Anesthesia Drugs Market has been classified into: General Anesthesia Drugs Local Anesthesia Drugs General Anesthesia Drugs dominated the market owing to the increasing number of major surgeries around the world since they helped doctors to create individualized anaesthetic plans that balance the patient's history with the anticipated surgical plan that maximizes patient safety. Local Anesthesia Drugs, on the other hand, is growing at the fastest CAGR rate since it is considered safer than general Anesthesia due to the absence of systemic side effects. By Application, the Global Anesthesia Drugs Market has been classified into: General Surgeries Plastic Surgery Cosmetic Surgeries Dental Surgeries Other Surgeries General Surgery dominated the market as anaesthetics are widely used in these surgical procedures. The market is expected to grow significantly over the forecasted period. The market is being driven by the growing number of surgeries, the ageing population with an increasing number of chronic diseases as well as technological advancements in Anesthesia. On the other hand, in 2019, nearly 1.8 million cosmetic surgical procedures were completed in the United States and 16.3 million cosmetic minimally-invasive procedures were performed, according to statistics from the American Society of Plastic Surgeons (ASPS). By Route of Administration, the Global Anesthesia Drugs Market has been classified into: Inhalation Intravenous Others Intravenous Drugs dominated the Anesthesia Drugs market as it offers various advantages such as more accurate dose delivery, better patient safety, lower rates of (postoperative nausea, vomiting, urinary retention, and malignant hyperthermia (a rare but serious side effect of general Anesthesia)), reduced risk of blood clots and pulmonary emboli (blood clots that move to the lungs). Regional Analysis: North America is witnessing a demand for Anesthesia Drugs due to the increasing number of surgeries in the region. The Anesthesia Drugs Market report includes Asia Pacific, North America, Europe and LAMEA. North America is witnessing a huge surge in surgical procedures each year. In this region, ailments like cancer, heart disease, and cardiovascular disease are highly prevalent and increasing at a rapid pace. There are a plethora of growth opportunities in this market due to the prevalence of these surgeries. Forecasts for the US Anesthesia Drugs market indicate a robust upsurge which will attribute to the growth of the North America Anesthesia Drugs market. Moreover, the Asia Pacific region is projected to grow at the highest rate due to its rapidly expanding healthcare infrastructure and the presence of major players. The adoption of Anesthesia Drugs is increasing rapidly in this region which will drive high revenue growth among these regional players. The report covers the following segments: Global, regional, and country-wise revenue growth is forecasted in the report between 2021 to 2028. This report divides the Global Anesthesia Drugs market into: By Type General Anaesthetics Propofol Sevoflurane Desflurane Dexmedetomidine Remifentanil Midazolam Local Anaesthetics Bupivacaine Ropivacaine Lidocaine Chloroprocaine Articaine Benzocaine By Application General Surgeries Plastic Surgery Cosmetic Surgeries Dental Surgeries By Route Of Administration Inhalation Anesthesia Drugs Intravenous Anesthesia Drugs Topical Anesthesia Drugs Anesthesia Drugs Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 7.03 billion Revenue forecast in 2030 USD 9.56 billion Growth rate CAGR of approximately 3.47% Base year for estimation 2021 Historical data 2015 – 2019 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By Application, By Route Of, Administration, By Region By Type General Anesthesia Drugs, Local Anesthesia Drugs By Application General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Others By Route Of Administration Inhalation, Intravenous, Others By Region Asia Pacific, North America, Europe, LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Charles River Laboratories International, Inc., The Jackson Laboratory, Laboratory Corporation of America Holdings (Covance), Perkin Elmer (Horizon Discovery Group plc), genOway, Envigo, JANVIER LABS, Taconic Biosciences Inc., Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc. Pricing and purchase options Avail customized purchase options to meet your exact research needs. Anesthesia Drugs Market Competitive Landscape Analysis The market report explores the recent significant developments by leading vendors, along with their in-depth company profiles, the key players included in the report are: Abbott Laboratories AbbVie Inc. Aspen Pharmacare Holdings Limited AstraZeneca PLC B. Braun Melsungen AG Baxter International Inc. Boehringer Ingelheim International GmbH Claris Lifesciences Limited Eisai Co. Ltd. F. Hoffmann-La Roche Ltd Fresenius SE & Co. KGaA Glenmark Pharmaceuticals Limited Hikma Pharmaceuticals PLC Hospira Inc Maruishi Pharmaceutical Co. Ltd. Mylan NV Pacira Pharmaceuticals Inc. Paion UK Ltd Pfizer Inc. Piramal Enterprises LTD Septodont Healthcare India Pvt. Ltd. Slayback Pharma LLC Teva Pharmaceutical Industries Limited Troikaa Pharmaceuticals Ltd. Recent Development: - On July 2021, Hikma Pharmaceuticals PLC (Hikma), an international pharma company, launched Succiniylcholine Chloride Injection, USP 20mg/mL in the US through its US affiliate, Hikma Pharmaceuticals USA Inc. In the treatment of COVID-19 patients Succinylcholine Chloride Injection, USP plays an important role. It is used to facilitate tracheal intubation as well as to relax skeletal muscles during a procedure or while on mechanical ventilation. On October 2016, the Agreement to acquire Janssen’s injectable Anesthesia and pain management products by Critical Care in the UK a wholly-owned subsidiary of Piramal Enterprises. Frequently Asked Question About This Report Which region has the highest market share and highest growth rate in the market? North America has the highest market share of over 31.4% and the Asia Pacific is growing at the highest growth rate in the global market. Who are the key players in the market? Major market participants include the following companies: Abbott Laboratories, AbbVie Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun Melsungen AG, Baxter International Inc., Boehringer Ingelheim International GmbH, Braun Melsungen AG etc. What is the anesthesia Drugs market growth? The anesthesia Drugs market is to grow at a CAGR of 3.47% between 2021 and 2028. How big is the anesthesia Drugs market? As of 2020, the market for anesthesia Drugs market size reached USD 6.8 Billion. What are the factors driving the market? The key drivers of the market are the increasing ageing population around the globe, rising number of surgeries, advances in technology in the delivery of Drugs, the development of specifically targeted medicines, moreover, the development of devices to monitor patient physiological parameters during and after Anesthesia, and reduced side effects of anaesthetics are driving factors that will boost the market growth. Based on Type, which segment accounted for the largest market share? On the basis of type, General anesthesia will dominate the Anesthesia Drugs market during the forecasted period. Sources https://m.economictimes.com/industry/healthcare/biotech/healthcare/covid-19-pandemic-will-lead-to-over-28-million-cancelled-surgeries-worldwide-study/articleshow/75757140.cms https://www.plasticsurgery.org/news/press-releases/american-society-of-plastic-surgeons-predicts-new-industry-trends-amidst-covid19-reopenings Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Anesthesia Drugs Market Segmentation 1.3.2 Geographic Scope Figure 02: Anesthesia Drugs Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.1.2.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Anesthesia Drugs Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Anesthesia Drugs Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table: Risk Assessment Chapter 3. Executive Summary 3.1 Anesthesia Drugs Market: Post-Covid-19 Figure 05: Impact of Covid-19 on Anesthesia Drugs Market 3.1.1 Actual Scenario Figure 06: Realistic Scenario: Anesthesia Drugs Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 07: Pessimistic Scenario: Anesthesia Drugs Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 08: Optimistic Scenario: Anesthesia Drugs Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 09: Local Anesthesia Drugs to Witness Highest CAGR in Anesthesia Drugs Market, By Type, During Forecast Period Figure 10: Cosmetic Surgeries to Witness Higher CAGR in Anesthesia Drugs Market for Application Segment during Forecast Period Figure 11: Inhalation Drugs for Route of Administration to Register Highest CAGR in Anesthesia Drugs Market during Forecast Period Figure 12: North America to Account for Largest Share of Global Anesthesia Drugs Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 13: Anesthesia Drugs Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Anesthesia Drugs Market 5.2.1 Global Anesthesia Drugs market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Anesthesia Drugs market, by region, 2020 - 2028 (USD Million) 5.4 Type Segment Analysis 5.4.1 Global Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 5.5 Application Segment Analysis 5.5.1 Global Anesthesia Drugs market, By Application, 2020 - 2028 (USD Million) 5.6 Route of Administration Segment Analysis 5.6.1 Global Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 5.7 By Route of Administration Business Analysis 5.8 Value Chain Analysis 5.9 Market Variable Analysis 5.9.1 Market Drivers Analysis 5.9.2 Market Restraints Analysis 5.10 Business Environment Analysis Tool 5.10.1 Anesthesia Drugs market PEST analysis 5.10.2 Anesthesia Drugs market Porter’s analysis 5.11 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 14 Anesthesia Drugs Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 15 Anesthesia Drugs Market Drivers and Their Impact 6.2.2 Restraints Figure 16 Anesthesia Drugs Market Restraints and Their Impact 6.2.3 Opportunities Figure 17 Anesthesia Drugs Market Opportunities and Their Impact 6.2.4 Challenges Figure 18 Anesthesia Drugs Market Challenges and Their Impact 6.3 Impact of Covid-19 on Anesthesia Drugs Market 6.4 Value Chain Analysis Figure 19 Value Chain Analysis: Anesthesia Drugs Market 6.5 Ecosystem Figure 20 Anesthesia Drugs Market: Ecosystem Table 1 Anesthesia Drugs Market: Ecosystem Figure 21 Revenue Shift in Anesthesia Drugs Market 6.6 Patent Analysis Table 2 Number of Patents Registered in Anesthesia Drugs Market in USA in Last 9 Years Figure 22 Top 9 Companies with Highest No. of Patents in Last 9 Years Figure 23 No of Patents Granted Per Year, 2019–2020 Table 3 List of Global Patents in Anesthesia Drugs Market 6.7 Trade Analysis Figure 24 Import Data for General Anesthesia, By Country, 2016–2020 (USD Thousand) Table 4 Import Data for Local Anesthesia, By Country, 2016–2020 (USD Thousand) Figure 25 Export Data for General Anesthesia, By Country, 2016–2020 (USD Thousand) Table 5 Export Data for Local Anesthesia, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 6 Anesthesia Drugs Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 7 Key Regulations: Anesthesia Drugs Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 8: Key Players market share Figure: Key players market share of companies 7.2 Manufacturers Anesthesia Drugs Manufacturing Sites, Area Served, Product Type 7.3 Anesthesia Drugs Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Anesthesia Drugs Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 8 Anesthesia Drugs Market, By Type, 2021–2028 (USD Million) Figure 26 Anesthesia Drugs Market, By Type Figure 27 Local Anesthesia Drugs Segment to Register Highest CAGR in Anesthesia Drugs Market During Forecast Period 8.3 Local Anesthesia Drugs 8.3.1 Local Anesthesia Drugs market, 2020 - 2028 (USD Million) Figure 28: Local Anesthesia Drugs market, 2020 - 2028 (USD Million) 8.4 General Anesthesia Drugs 8.4.1 General Anesthesia Drugs market, 2020 - 2028 (USD Million) Figure 29: General Anesthesia Drugs market, 2020 - 2028 (USD Million) Chapter 9. Global Anesthesia Drugs Market: Application Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 9: Anesthesia Drugs Market, By Application, 2021–2028 (USD Million) Figure 30: Anesthesia Drugs Market, By Application, 2021–2028 (USD Million) Figure 31: Cosmetic Surgeries Segment to Register Highest CAGR in Anesthesia Drugs Market during Forecast Period 9.3 General Surgeries 9.3.1General Surgeries market, 2020 - 2028 (USD Million) Figure 32: General Surgeries market, 2020 - 2028 (USD Million) 9.4 Plastic Surgeries 9.4.1 Plastic Surgeries market, 2020 - 2028 (USD Million) Figure 33: Plastic Surgeries market, 2020 - 2028 (USD Million) 9.5 Cosmetic Surgeries 9.5.1 Cosmetic Surgeries market, 2020 - 2028 (USD Million) Figure 34: Cosmetic Surgeries market, 2020 - 2028 (USD Million) 9.6 Dental Surgeries 9.6.1 Dental Surgeries market, 2020 - 2028 (USD Million) Figure 35: Dental Surgeries market, 2020 - 2028 (USD Million) 9.7 Others 9.7.1 Other Surgeries market, 2020 - 2028 (USD Million) Figure 36: Other Surgeries market, 2020 - 2028 (USD Million) Chapter 10. Global Anesthesia Drugs Market: Route of Administration Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2020-2028) Table 10: Anesthesia Drugs Market, By Route of Administration, 2021–2028 (USD Million) Figure 37: Anesthesia Drugs Market, By Route of Administration, 2021–2028 (USD Million) Figure 38: Cosmetic Surgeries Segment to Register Highest CAGR in Anesthesia Drugs Market during Forecast Period 10.3 Inhalation 10.3.1 Inhalation market, 2020 - 2028 (USD Million) Figure 39: Inhalation market, 2020 - 2028 (USD Million) 10.4 Intravenous 10.4.1 Intravenous market, 2020 - 2028 (USD Million) Figure 40: Intravenous market, 2020 - 2028 (USD Million) 10.5 Others 10.5.1 Other Route of Administration market, 2020 - 2028 (USD Million) Figure 41: Other Route of Administration market, 2020 - 2028 (USD Million) Chapter 11. Global Anesthesia Drugs Market: Regional Outlook 11.1 North America Figure 42: North America Anesthesia Drugs Market, By Revenue Forecast (2020-2028) 11.1.1 North America Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) Table 11: North America Anesthesia Drugs Market, by Country, 2020-2028 Figure 43: North America Anesthesia Drugs Market 11.1.2 North America Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Table12: North America Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 44: North America Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.1.3 North America Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Table 13: North America Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 45: North America Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.1.4 North America Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Table 14: North America Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 46: North America Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.1.5 U.S. 11.1.5.1 U.S. Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 47: U.S. Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.1.5.2 U.S. Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 48: U.S. Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.1.5.3 U.S. Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 49: U.S. Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.1.6 Canada 11.1.6.1 Canada Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 50: Canada Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.1.6.2 Canada Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 51: Canada Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.1.6.3 Canada Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 52: Canada Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.1.6.4 Canada Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 53: Canada Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.2 Europe Figure 54: Europe Anesthesia Drugs Market, By Revenue Forecast (2020-2028) 11.2.1 Europe Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) Table 15: Europe Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) Figure 55: Europe Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) 11.2.2 Europe Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Table 16: Europe Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 56: Europe Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.2.3 Europe Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Table 17: Europe Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 57: Europe Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.2.4 Europe Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Table 18: Europe Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 58: Europe Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.2.5 U.K. 11.2.5.1 U.K. Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 59: U.K. Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.2.5.2 U.K. Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 60: U.K. Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.2.5.3 U.K. Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 61: U.K. Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.2.6 Germany 11.2.6.1 Germany Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 62: Germany Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.2.6.2 Germany Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 63: Germany Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.2.6.3 Germany Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 64: Germany Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.2.7 France 11.2.7.1 France Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 65: France Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.2.7.2 France Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 66: France Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.2.7.3 France Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 67: France Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.2.8 Rest of Europe 11.2.8.1 Rest of Europe Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 68: Rest of Europe Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.2.8.2 Rest of Europe Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 69: Rest of Europe Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.2.8.3 Rest of Europe Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 70: Rest of Europe Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.3 Asia Pacific Figure 71: Asia Pacific Anesthesia Drugs Market, By Revenue Forecast (2020-2028) 11.3.1 Asia Pacific Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) Table 19: Asia Pacific Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) Figure 72: Asia Pacific Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) 11.3.2 Asia Pacific Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Table 20: Asia Pacific Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 73: Asia Pacific Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.3.3 Asia Pacific Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Table 21: Asia Pacific Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 74: Asia Pacific Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.3.4 Asia Pacific Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Table 22: Asia Pacific Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 75: Asia Pacific Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.3.5 China 11.3.5.1 China Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 76: China Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.3.5.2 China Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 77: China Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.3.5.3 China Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 78: China Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.3.6 India 11.3.6.1 India Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 79: India Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.3.6.2 India Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 80: India Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.3.6.3 India Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 81: India Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.3.7 Japan 11.3.7.1 Japan Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 83: Japan Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.3.7.2 Japan Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 84: Japan Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.3.7.3 Japan Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 85: Japan Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.3.8 South Korea 11.3.8.1 South Korea Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 86: South Korea Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.3.8.2 South Korea Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 87: South Korea Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.3.8.3 South Korea Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 88: South Korea Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.3.9 Rest of APAC 11.3.9.1 Rest of APAC Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 89: Rest of APAC Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.3.9.2 Rest of APAC Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 90: Rest of APAC Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.3.9.3 Rest of APAC Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 91: Rest of APAC Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.4 Latin America Figure 92: Latin America Anesthesia Drugs Market, By Revenue Forecast (2020-2028) 11.4.1 Latin America Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) Table 23: Latin America Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) Figure 93: Latin America Anesthesia Drugs market, by country, 2020 - 2028 (USD Million) 11.4.2 Latin America Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Table 24: Latin America Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 94: Latin America Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.4.3 Latin America Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Table 25: Latin America Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 95: Latin America Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.4.4 Latin America Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Table 26: Latin America Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 96: Latin America Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.4.5 Brazil 11.4.5.1 Brazil Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 97: Brazil Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.4.5.2 Brazil Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 98: Brazil Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.4.5.3 Brazil Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 99: Brazil Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.4.6 Mexico 11.4.6.1 Mexico Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 100: Mexico Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.4.6 2 Mexico Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 101: Mexico Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.4.6.3 Mexico Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 103: Mexico Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.4.6.4 Mexico Anesthesia Drugs market, by By Route of Administration, 2020 - 2028 (USD Million) Figure 104: Mexico Anesthesia Drugs market, by By Route of Administration, 2020 - 2028 (USD Million) 11.4.7 Rest of the Latin America 11.4.7.1 Rest of the Latin America Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 105: Rest of the Latin America Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.4.7.2 Rest of the Latin America Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 106: Rest of the Latin America Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 9.4.8.3 Rest of the Latin America Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 107: Rest of the Latin America Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.5 MEA Figure 108: MEA Anesthesia Drugs Market, By Revenue Forecast (2020-2028) 11.5.1 MEA Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) Figure 109: MEA Anesthesia Drugs market, by Type, 2020 - 2028 (USD Million) 11.5.2 MEA Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) Figure 110: MEA Anesthesia Drugs market, by Application, 2020 - 2028 (USD Million) 11.5.3 MEA Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) Figure 111: MEA Anesthesia Drugs market, by Route of Administration, 2020 - 2028 (USD Million) 11.5.4 MEA Anesthesia Drugs market, by By Route of Administration, 2020 - 2028 (USD Million) Figure 112: MEA Anesthesia Drugs market, by By Route of Administration, 2020 - 2028 (USD Million) Chapter 12. Competitive Landscape 12.1 Abbott Laboratories 12.1.1 Company overview 12.1.2 Financial performance 12.1.3 Product Portfolio Analysis 12.1.4 Business Strategy & Recent Development 12.2 AbbVie Inc. 12.2 .1 Company overview 12.2 .2 Financial performance 12.2 .3 Product Portfolio Analysis 12.2 .4 Business Strategy & Recent Development 12.3 Aspen Pharmacare Holdings Limited 12.3.1 Company overview 12.3.2 Financial performance 12.3.3 Product Portfolio Analysis 12.3.4 Business Strategy & Recent Development 12.4 AstraZeneca PLC 12.4.1 Company overview 12.4.2 Financial performance 12.4.3 Product Portfolio Analysis 12.4.4 Business Strategy & Recent Development 12.5 B. Braun Melsungen AG 12.5.1 Company overview 12.5.2 Financial performance 12.5.3 Product Portfolio Analysis 12.5.4 Business Strategy & Recent Development 12.6 Baxter International Inc. 12.6.1 Company overview 12.6.2 Financial performance 12.6.3 Product Portfolio Analysis 12.6.4 Business Strategy & Recent Development 12.7 Boehringer Ingelheim International GmbH 12.7.1 Company overview 12.7.2 Financial performance 12.7.3 Product Portfolio Analysis 12.7.4 Business Strategy & Recent Development 12.8 Claris Lifesciences Limited 12.8.1 Company overview 12.8.2 Financial performance 12.8.3 Product Portfolio Analysis 12.8.4 Business Strategy & Recent Development 12.9 Eisai Co. Ltd. 12.9.1 Company overview 12.9.2 Financial performance 12.9.3 Product Portfolio Analysis 12.9.4 Business Strategy & Recent Development 12.10 F. Hoffmann-La Roche Ltd 12.10.1 Company overview 12.10.2 Financial performance 12.10.3 Product Portfolio Analysis 12.10.4 Business Strategy & Recent Development 12.11 Fresenius SE & Co. KGaA 12.11.1 Company overview 12.11.2 Financial performance 12.11.3 Product Portfolio Analysis 12.11.4 Business Strategy & Recent Development 12.12 Glenmark Pharmaceuticals Limited 12.12.1 Company overview 12.12.2 Financial performance 12.12.3 Product Portfolio Analysis 12.12.4 Business Strategy & Recent Development 12.13 Hikma Pharmaceuticals PLC 12.13.1 Company overview 12.13.2 Financial performance 12.13.3 Product Portfolio Analysis 12.13.4 Business Strategy & Recent Development 12.14 Hospira Inc 12.14.1 Company overview 12.14.2 Financial performance 12.14.3 Product Portfolio Analysis 12.14.4 Business Strategy & Recent Development 12.15 Maruishi Pharmaceutical Co. Ltd. 12.15.1 Company overview 12.15.2 Financial performance 12.15.3 Product Portfolio Analysis 12.15.4 Business Strategy & Recent Development 12.16 Mylan NV 12.16.1 Company overview 12.16.2 Financial performance 12.16.3 Product Portfolio Analysis 12.16.4 Business Strategy & Recent Development 12.17 Pacira Pharmaceuticals Inc. 12.17.1 Company overview 12.17.2 Financial performance 12.17.3 Product Portfolio Analysis 12.17.4 Business Strategy & Recent Development 12.18 Paion UK Ltd 12.18.1 Company overview 12.18.2 Financial performance 12.18.3 Product Portfolio Analysis 12.18.4 Business Strategy & Recent Development 12.19 Pfizer Inc. 12.19.1 Company overview 12.19.2 Financial performance 12.19.3 Product Portfolio Analysis 12.19.4 Business Strategy & Recent Development 12.20 Piramal Enterprises LTD 12.20.1 Company overview 12.20.2 Financial performance 12.20.3 Product Portfolio Analysis 12.20.4 Business Strategy & Recent Development 12.21 Septodont Healthcare India Pvt. Ltd. 12.21.1 Company overview 12.21.2 Financial performance 12.21.3 Product Portfolio Analysis 12.21.4 Business Strategy & Recent Development 12.22 Slayback Pharma LLC 12.22.1 Company overview 12.22.2 Financial performance 12.22.3 Product Portfolio Analysis 12.22.4 Business Strategy & Recent Development 12.23 Teva Pharmaceutical Industries Limited 12.23.1 Company overview 12.23.2 Financial performance 12.23.3 Product Portfolio Analysis 12.23.4 Business Strategy & Recent Development 12.24 Troikaa Pharmaceuticals Ltd. 12.24.1 Company overview 12.24.2 Financial performance 12.24.3 Product Portfolio Analysis 12.24.4 Business Strategy & Recent Development